Autio, K. A., Antonarakis, E. S., Mayer, T. M., Shevrin, D. H., Stein, M. N., Vaishampayan, U. N., . . . Scher, H. I. (2021). Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier.
Cita Chicago Style (17a ed.)Autio, Karen A., et al. Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier, 2021.
Cita MLA (8a ed.)Autio, Karen A., et al. Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier, 2021.